Literature DB >> 21191413

Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation.

Yoko Yoshihisa1, Teruhiko Makino, Kenji Matsunaga, Ayumi Honda, Osamu Norisugi, Riichiro Abe, Hiroshi Shimizu, Tadamichi Shimizu.   

Abstract

Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that has an essential role in the pathophysiology of experimental allergic inflammation. Recent findings suggest that MIF is involved in several allergic disorders, including atopic dermatitis (AD). In this study, the role of MIF in allergic skin inflammation was examined using a murine model of AD elicited by epicutaneous sensitization with ovalbumin (OVA). We observed the number of skin-infiltrating eosinophils to significantly increase in OVA-sensitized MIF transgenic (Tg) mice compared with their wild-type (WT) littermates. On the other hand, eosinophils were virtually absent from the skin of MIF knockout (KO) mice and failed to infiltrate their skin after repeated epicutaneous sensitization with OVA. The mRNA expression levels of eotaxin and IL-5 were significantly increased in OVA-sensitized skin sites of MIF Tg mice, but were significantly decreased in MIF KO mice in comparison with the levels in WT littermates. Eotaxin expression was induced by IL-4 stimulation in fibroblasts in MIF Tg mice, but not in MIF KO mice. These findings indicate that MIF can induce eosinophil accumulation in the skin. Therefore, the targeted inhibition of MIF might be a promising new therapeutic strategy for allergic skin diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191413     DOI: 10.1038/jid.2010.418

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy.

Authors:  Li Rebekah Feng; Brian S Wolff; Nada Lukkahatai; Alexandra Espina; Leorey N Saligan
Journal:  Cancer Nurs       Date:  2017 May/Jun       Impact factor: 2.592

2.  Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization.

Authors:  Rituparna Das; Jeremy E Moss; Eve Robinson; Scott Roberts; Rebecca Levy; Yuka Mizue; Lin Leng; Courtney McDonald; Robert E Tigelaar; Christina A Herrick; Richard Bucala
Journal:  J Clin Immunol       Date:  2011-05-11       Impact factor: 8.317

3.  Alleviation of Atopic Dermatitis Lesions by a Benzylideneacetophenone Derivative via the MAPK Signaling Pathway.

Authors:  Bongjun Sur; Seungmin Kang; Mijin Kim; Seikwan Oh
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF).

Authors:  Fumi Varyani; Stephan Löser; Kara J Filbey; Yvonne Harcus; Claire Drurey; Marta Campillo Poveda; Orhan Rasid; Madeleine P J White; Danielle J Smyth; François Gerbe; Philippe Jay; Rick M Maizels
Journal:  Mucosal Immunol       Date:  2022-03-14       Impact factor: 7.313

5.  The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.

Authors:  Kirsty E Russell; Kian Fan Chung; Colin J Clarke; Andrew L Durham; Patrick Mallia; Joseph Footitt; Sebastian L Johnston; Peter J Barnes; Simon R Hall; Karen D Simpson; Malcolm R Starkey; Philip M Hansbro; Ian M Adcock; Coen H Wiegman
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

6.  Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis.

Authors:  Chun-Kwok Wong; Karen Ming-Lam Leung; Huai-Na Qiu; Joyce Yin-Sau Chow; Angela On Kei Choi; Christopher Wai-Kei Lam
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.

Authors:  Yuka Nagata; Yoko Yoshihisa; Kenji Matsunaga; Mati Ur Rehman; Nobuyoshi Kitaichi; Nobuyuki Kitaichi; Tadamichi Shimizu
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

8.  Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis.

Authors:  Shaobing Xie; Hua Zhang; Fengjun Wang; Zhihai Xie; Weihong Jiang; Kelei Gao
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

9.  Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders.

Authors:  Nader Pazyar; Amir Feily; Reza Yaghoobi
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

10.  Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.

Authors:  Tania Brocks; Oleg Fedorchenko; Nicola Schliermann; Astrid Stein; Ute M Moll; Seth Seegobin; Manfred Dewor; Michael Hallek; Yvonne Marquardt; Katharina Fietkau; Ruth Heise; Sebastian Huth; Herbert Pfister; Juergen Bernhagen; Richard Bucala; Jens M Baron; Guenter Fingerle-Rowson
Journal:  FASEB J       Date:  2016-10-19       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.